Clinical Trial Update: Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of IBI311 for inactive Thyroid-associated ophthalmopathy (thyroid eye disease) is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy
• Thyroid Eye Disease

Drugs mentioned

• IBI311

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Thyroid Associated Ophthalmopathies | Phase 4 | Status: RECRUITING